These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7835639)

  • 21. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.
    Cryan JF; Hoyer D; Markou A
    Biol Psychiatry; 2003 Jul; 54(1):49-58. PubMed ID: 12842308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period.
    Trzeciak HI; Herman ZS; Szkilnik R; Opiełka L; Laskawiec G; Kryk A; Kmicińska M; Stańda J; Obuchowicz E; Bień E
    Pol J Pharmacol Pharm; 1986; 38(1):9-20. PubMed ID: 3763488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the mechanism of central stimulation action of fencamfamine.
    DeLucia R; Bernardi MM; Scavone C; Aizenstein ML
    Gen Pharmacol; 1984; 15(5):407-10. PubMed ID: 6150875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence.
    Spain JW; Klingman GI
    J Pharmacol Exp Ther; 1985 Aug; 234(2):415-24. PubMed ID: 4040569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
    Iijima M; Koike H; Chaki S
    Behav Brain Res; 2013 Jun; 246():24-8. PubMed ID: 23473878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in sodium, potassium-ATPase induced by repeated fencamfamine: the roles of cyclic AMP-dependent protein kinase and the nitric oxide-cyclic GMP pathway.
    Munhoz CD; Glezer I; Kawamoto EM; Araújo AP; Lepscha LB; Planeta CS; DeLucia R; Scavone C
    Neuropharmacology; 2003 Dec; 45(8):1151-9. PubMed ID: 14614957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychostimulant withdrawal as an inducing condition in animal models of depression.
    Barr AM; Markou A
    Neurosci Biobehav Rev; 2005; 29(4-5):675-706. PubMed ID: 15893821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 'crash' course on psychostimulant withdrawal as a model of depression.
    Barr AM; Markou A; Phillips AG
    Trends Pharmacol Sci; 2002 Oct; 23(10):475-82. PubMed ID: 12368072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swimming capacity of mice after prolonged treatment with psychostimulants. III. Effect of fencamfamine on swimming endurance and availability of metabolic substrates.
    Estler CJ; Gabrys MK
    Psychopharmacology (Berl); 1979 Jun; 63(3):281-4. PubMed ID: 39309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
    Russig H; Murphy CA; Feldon J
    Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Behavioral correlations of gradual forced administration of psychoactive drugs].
    Shabanov PD; Lebedev AA
    Eksp Klin Farmakol; 2011; 74(6):3-9. PubMed ID: 21870767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration.
    Murphy CA; Russig H; Pezze MA; Ferger B; Feldon J
    Neuropharmacology; 2003 Jun; 44(7):926-39. PubMed ID: 12726824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum.
    Renard GM; Sotomayor-Zarate R; Blanco EH; Gysling K
    J Neurosci Res; 2014 Jul; 92(7):937-43. PubMed ID: 24753218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxide.
    Froger-Colléaux C; Rompion S; Guillaume P; Porsolt RD; Castagné V; Moser P
    J Pharmacol Toxicol Methods; 2011; 64(1):81-8. PubMed ID: 21406242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
    White W; White IM
    Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fencamfamine.
    DeLucia R; Planeta CS
    Gen Pharmacol; 1990; 21(2):161-3. PubMed ID: 1970543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiogenic action of caffeine: an experimental study in rats.
    Bhattacharya SK; Satyan KS; Chakrabarti A
    J Psychopharmacol; 1997; 11(3):219-24. PubMed ID: 9305413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acquisition, retention and reversal of spatial learning in the morris water maze task following withdrawal from an escalating dosage schedule of amphetamine in wistar rats.
    Russig H; Durrer A; Yee BK; Murphy CA; Feldon J
    Neuroscience; 2003; 119(1):167-79. PubMed ID: 12763078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.